GreenPeptide Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY44.96 |
Market Cap |
JPY11.63 B |
Shares Outstanding |
41.99 M |
Public Float |
40.61 M |
Address |
Fukuoka Bio Incubation Center 402 Kurume Fukuoka 839 Japan |
Employees | - |
Website | http://www.brightpathbio.com |
Updated | 07/08/2019 |
BrightPath Biotherapeutics Co., Ltd. engages in the drug development business. It focuses on the development of cancer immunotherapies. Its product candidates are based on peptide vaccine technology that stimulates a potent immune response to tumor-associated antigens. |